Riskpilot← Back to searchSign inGet full accessMX Adjuvac AB
ABActiveOrg 5591141097Economic activity was not specified by tax authority · NACE 0000Est. 20170 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -227K
0% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK -227K | +0% |
| Total assets | SEK 717K | -24% |
| Equity | SEK 717K | -24% |
| Employees | 0 | — |
Legal name
MX Adjuvac AB
Org number
5591141097
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
1 juni 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet ska vara att utveckla adjuvans för vacciner och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | −13 | — | — | — | — | — | — | — |
| Depreciation & amort. | −0 | −227 | −227 | −227 | −227 | −227 | −227 | −227 |
| EBIT | −13 | −227 | −227 | −227 | −227 | −227 | −227 | −227 |
| Net financials | — | — | — | — | — | — | — | — |
| Profit before tax | −13 | −227 | −227 | −227 | −227 | −227 | −227 | −227 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −13 | −227 | −227 | −227 | −227 | −227 | −227 | −227 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 2 305 | 2 078 | 1 851 | 1 624 | 1 398 | 1 171 | 944 | 717 |
| Equity | 2 305 | 2 078 | 1 851 | 1 624 | 1 398 | 1 171 | 944 | 717 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | — | — | — | — | — | — | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20172024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20172024
Return on equity
-31.7%
This company
18.4%
Market median
-272% vs market
20172024
Net profit margin
-22700000.0%
This company
8.1%
Market median
-280247014% vs market
20172024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-06-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JK Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
NI Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
PH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
BD Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
AC Authorized Recipient of Service | Authorized Recipient of Service | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MX Adjuvac AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jette Kjeldal | Chief Executive Officer | 0 companies |
| Nicholas Ian Challoner | Chief Executive Officer | 0 companies |
| Peter Holm Tygesen | Chief Executive Officer | 0 companies |
| Björn Daniel Wiklund | Authorized Recipient of Service | 0 companies |
| Anders Christer Malmström | Authorized Recipient of Service | 0 companies |
| Jørgen Peter Brodersen | Deputy Board Member | 0 companies |
| Erik Jan Bartels | Deputy Board Member | 0 companies |